Table 2.
Clinical data for management of retained placenta by treatment group (ITT).
| Variable | Nitroglycerin (n = 55) | Placebo (n = 56) | P value | Relative risk (RR) 95% CI |
|---|---|---|---|---|
| Placental detachment | ||||
| n (%) | 20 (36.4) | 13 (23.2) | 0.13 | 1.57 (0.87; 2.83) |
|
| ||||
| Blood loss after treatment (mL) | n = 51 | n = 54 | ||
| Mean (SD) | 465 (463) | 560 (468) | 0.30 | |
| Median (range) | 250 (50; 2200) | 400 (0; 1800) | ||
|
| ||||
| Total blood loss (mL) | n = 51 | n = 54 | ||
| Mean (SD) | 1018 (612) | 1098 (658) | 0.52 | |
| Median (range) | 900 (200; 2500) | 950 (150; 3000) | ||
|
| ||||
| Total blood loss ≥1000 mL | ||||
| n (%) | 24 (43.6) | 26 (46.4) | 0.77 | 0.94 (0.62; 1.42) |
Intention to treat group, ITT: all randomized patients, including 4 patients who did not receive study medication and 2 patients who only received 0.5 mg nitroglycerin.